EVALUATING THE OUTCOMES OF BRAIN SURGERY COMPLICATIONS IN PATIENTS
Keywords:
Craniotomy Surgery, Postoperative Complications, Quality of Life Assessment, Brain TumorsAbstract
Background: Surgery of brain tumors is a reliable predictor for surgical safety and efficacy. After an elective craniotomy of the surgical excision of a brain tumor, patients are frequently admitted to the intensive care unit (ICU) in observation. Objective: This study aimed to assess clinical findings related to complications after brain surgery. Patients and methods: 80 patients underwent brain tumor surgery and were admitted to the intensive care unit. Their ages ranged between 30-70 years. Data were collected before, during, and after surgery for patients from different hospitals in Iraq for the study period, which ranged from April 12, 2022, to October 25, 2023. Questionnaires were administered to evaluate patients' pain ratings and quality of life. Common brain surgical complications affecting patients after craniotomy for brain tumor surgery have been identified. Results: According to craniotomy for brain tumor surgery findings, our outcomes shown males had 56 cases and females had 24 cases. The main locations of brain tumours were temporal, had 31 cases; and frontal had 23 cases; surgery duration was 153.6 ± 24.6 min; anesthesia time was 220 ± 34.86 min; intraoperative bleeding had 2 cases; ICU admission had only one case, length of stay in hospital < 4 days with 62 cases, post-operative had 14 cases, which most factors were infection with 6 cases and cerebrospinal fluid (CSF) leak with 3 cases, the most items improved quality of life at patients were physical functioning with 1.02 ± 0.02, symptoms with 0.62 ± 0.31, and daily activity with 0.85 ± 0.45. Conclusion: PONV is just one of the common issues that arise after someone has had a brain operation. Some 20% of them had neurologic deficits that were bad enough to require them staying in an ICU. There are those individuals who may face complications in the aftermath if they, before coming, had motor deficits or bled during surgery.
References
Kelly DF. Neurosurgical postoperative care. Neurosurg Clin N Am 1994;5: 789–810.
Bruder NJ. Awakening management after neurosurgery for intracranial tumours. Curr Opin Anaesthesiol 2002;15:477–82.
Basali A, Mascha EJ, Kalfas I, et al. Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology 2000;93:48–54.
Rhondali O, Genty C, Halle C, et al. Do patients still require admission to an intensive care unit after elective craniotomy for brain surgery? J Neurosurg Anesthesiol 2011;23:118–23.
Beauregard CL, Friedman WA. Routine use of postoperative ICU care for elective craniotomy: a cost-benefit analysis. Surg Neurol 2003;60:483–9.
Zimmerman JE, Junker CD, Becker RB, et al. Neurological intensive care admissions: identifying candidates for intermediate care and the services they receive. Neurosurgery 1998;42:91–101.
Magni G, La Rosa I, Gimignani S, et al. Early postoperative complications after intracranial surgery: comparison between total intravenous and balanced anesthesia. J Neurosurg Anesthesiol 2007;19:229–34.
Magni G, Rosa IL, Melillo G, et al. A comparison between sevoflurane and desflurane anesthesia in patients undergoing craniotomy for supratentorial intracranial surgery. Anesth Analg 2009;109:567–71.
Bruder N, Ravussin P. Recovery from anesthesia and postoperative extubation of neurosurgical patients: a review. J Neurosurg Anesthesiol 1999;11:282–93.
Manninen PH, Raman SK, Boyle K, et al. Early postoperative complications following neurosurgical procedures. Can J Anaesth 1999;46:7–14.
Neufeld SM, Newburn-Cook CV. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis. J Neurosurg Anesthesiol 2007;19:10–7.
Flexman AM, Ng JL, Gelb AW. Acute and chronic pain following craniotomy. Curr Opin Anaesthesiol 2010;23:551–7.
Milligan TA, Hurwitz S, Bromfield EB. Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery. Neurology 2008;71:665–9.
Komotar RJ, Raper DM, Starke RM, et al. Prophylactic antiepileptic drug therapy in patients undergoing supratentorial meningioma resection: a systematic analysis of efficacy. J Neurosurg 2011;115:483–90.
Kvam DA, Loftus CM, Copeland B, et al. Seizures during the immediate postoperative period. Neurosurgery 1983;12:14–7.
De Santis A, Villani R, Sinisi M, et al. Add-on phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 2002;43:175–82.
Gerlach R, Raabe A, Scharrer I, et al. Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors, and clinical outcome. Neurol Res 2004;26:61–6.
Palmer JD, Sparrow OC, Iannotti F. Postoperative hematoma: a 5-year survey and identification of avoidable risk factors. Neurosurgery 1994;35:1061–4.
Zetterling M, Ronne-Engstrom E. High intraoperative blood loss may be a risk factor for postoperative hematoma. J Neurosurg Anesthesiol 2004;16: 151–5.
Taylor WA, Thomas NW, Wellings JA, et al. Timing of postoperative intracranial hematoma development and implications for the best use of neurosurgical intensive care. J Neurosurg 1995;82:48–50.
Ziai WC, Varelas PN, Zeger SL, et al. Neurologic intensive care resource use after brain tumor surgery: an analysis of indications and alternative strategies. Crit Care Med 2003;31:2782–7.
Bui JQ, Mendis RL, van Gelder JM, et al. Is postoperative intensive care unit admission a prerequisite for elective craniotomy? J Neurosurg 2011;115: 1236–41.
Hanak BW, Walcott BP, Nahed BV, et al. Postoperative intensive care unit requirements after elective craniotomy. World Neurosurg 2014;81:165–72.
Pang BC, Wan WH, Lee CK, Khu KJ, Ng WH. The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge. Ann Acad Med Singapore. 2007;36:358–63.
Sawaya R. Extent of resection in malignant gliomas: A critical summary. J Neurooncol. 1999;42:303–5.
Ryken TC, Frankel B, Julien T, Olson JJ. Surgical management of newly diagnosed glioblastoma in adults: Role of cytoreductive surgery. J Neurooncol. 2008;89:271–86.
Moiyadi AV. Surgical management of malignant gliomas - Challenges and strategies. Int J Neurol Neurosurg. 2009;1:21–7.
Mangram AJ. Hospital Infection Control Practices Advisory Committee (HICPAC) and Centers for Disease Control and Prevention (CDC). Guidelines for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;24:247–78.
Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery. 1998;42:1044–55.
Brell M, Ibáñez J, Caral L, Ferrer E. Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 2000;142:739–50.
Chang SM, Parney IF, McDermott M, Barker FG, 2nd, Schmidt MH, Huang W, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg. 2003;98:1175–81.
Rabadán AT, Hernandez D, Eleta M, Pietrani M, Baccanelli M, Christiansen S, et al. Factors related to surgical complications and their impact on the functional status in 236 open surgeries for malignant tumors in a Latino-American hospital. Surg Neurol. 2007;68:412–20. discussion 420.
Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ ALA-Glioma Study Group. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicenter phase III trial. Lancet Oncol. 2006;7:392–401.
Choudhari KA. Commentary: Surgery for glioblastoma and the influence of technology on outcomes between developed and developing parts of the world. Surg Neurol. 2010;73 (2):e16.
